A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2
Deep vein thrombosis (DVT) is the formation of a blood clot typically in the deep veins of the extremities. The risk factors for venous thrombosis are primarily related to hypercoagulability, which can be genetic, acquired, or due to immobilization and venous stasis. The Johnson and Johnson (J&J...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2022/1292754 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563416038899712 |
|---|---|
| author | Ayrton Bangolo Jeffin Cherian Mohamed Ahmed Ali Atoot Bhavna Gupta Adam Atoot |
| author_facet | Ayrton Bangolo Jeffin Cherian Mohamed Ahmed Ali Atoot Bhavna Gupta Adam Atoot |
| author_sort | Ayrton Bangolo |
| collection | DOAJ |
| description | Deep vein thrombosis (DVT) is the formation of a blood clot typically in the deep veins of the extremities. The risk factors for venous thrombosis are primarily related to hypercoagulability, which can be genetic, acquired, or due to immobilization and venous stasis. The Johnson and Johnson (J&J) vaccine developed against the novel SARS-CoV-2 has been linked to more specific cases of thrombosis, associated with low platelet levels similar to that seen in heparin-induced thrombocytopenia. In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine. |
| format | Article |
| id | doaj-art-30f7a372d65745999a6b14f51cff4d08 |
| institution | Kabale University |
| issn | 2090-6633 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Infectious Diseases |
| spelling | doaj-art-30f7a372d65745999a6b14f51cff4d082025-02-03T01:20:17ZengWileyCase Reports in Infectious Diseases2090-66332022-01-01202210.1155/2022/1292754A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2Ayrton Bangolo0Jeffin Cherian1Mohamed Ahmed2Ali Atoot3Bhavna Gupta4Adam Atoot5Department of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineDepartment of AnesthesiaDepartment of Hematology and OncologyDepartment of Internal MedicineDeep vein thrombosis (DVT) is the formation of a blood clot typically in the deep veins of the extremities. The risk factors for venous thrombosis are primarily related to hypercoagulability, which can be genetic, acquired, or due to immobilization and venous stasis. The Johnson and Johnson (J&J) vaccine developed against the novel SARS-CoV-2 has been linked to more specific cases of thrombosis, associated with low platelet levels similar to that seen in heparin-induced thrombocytopenia. In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine.http://dx.doi.org/10.1155/2022/1292754 |
| spellingShingle | Ayrton Bangolo Jeffin Cherian Mohamed Ahmed Ali Atoot Bhavna Gupta Adam Atoot A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 Case Reports in Infectious Diseases |
| title | A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 |
| title_full | A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 |
| title_fullStr | A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 |
| title_full_unstemmed | A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 |
| title_short | A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 |
| title_sort | case report of dvt following the johnson and johnson vaccine against the novel sars cov 2 |
| url | http://dx.doi.org/10.1155/2022/1292754 |
| work_keys_str_mv | AT ayrtonbangolo acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT jeffincherian acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT mohamedahmed acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT aliatoot acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT bhavnagupta acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT adamatoot acasereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT ayrtonbangolo casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT jeffincherian casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT mohamedahmed casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT aliatoot casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT bhavnagupta casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 AT adamatoot casereportofdvtfollowingthejohnsonandjohnsonvaccineagainstthenovelsarscov2 |